《美股業績》波音(BA.US)上季蝕12.42億美元 隔夜股價跌7.5%
波音(BA.US)公佈,今年首季虧損按年擴大逾1倍至12.42億美元,受累於飛機相關費用及新成本的27億美元開支,每股核心虧損2.75美元,收入下降8%至139.9億美元。
波音宣佈由於認證問題及需求疲軟後再次推遲投入使用,將暫停生產777X飛機直至2025年,較原先的2023年再度推遲,消息拖累公司股價隔夜下跌7.5%至154.46美元。
公司稱,暫停777-9的生產將增加15億美元的新成本,因777需要更長的安全認證時間表,不過停產將有助於最大限度地減少庫存及需要改裝的飛機數量。
波音重申,預計第二季737 MAX的產量將達到每月31架,公司有望在今年恢復正現金流,因此無立即籌集資金的需要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.